NCT00000328撤回2 期
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 撤回
- 试验地点
- 2
- 主要终点
- Opioid agonist rating
研究概览
简要总结
The purpose of this study is to compare the clinical efficacy of the buprenorphine/naloxone combination tablet to methadone for opioid maintenance treatment.
详细描述
S/A brief "Summary for the Public"
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 65 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Individuals must be at least 18 years of age, currently opioid dependent and meet FDA criteria for narcotic maintenance treatment. Co-morbid substance abuse or dependence disorders may also be present. Individuals must be healthy despite drug dependency.
排除标准
- •Individuals with evidence of an active Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) Axis I psychiatric disorder (e.g. psychosis, manic-depressive illness, organic psychiatric disorders), significant medical illness (e.g. liver or cardiovascular disease) or pregnant female subjects are excluded from study participation.
结局指标
主要结局
Opioid agonist rating
Opioid antagonist rating
Compliance
Addiction Severity Index (ASI) Composite Score Rating
Drug use
Retention
Medication identification
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
撤回
2 期
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1Heroin DependenceOpioid-Related DisordersNCT00000326University of Colorado, Denver
已完成
不适用
Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid DependenceOpioid-Related DisordersNCT00134914National Institute on Drug Abuse (NIDA)10
撤回
2 期
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2Heroin DependenceOpioid-Related DisordersNCT00000327University of Colorado, Denver
已完成
4 期
Long-acting Buprenorphine vs. Naltrexone Opioid Treatments in CJS-involved AdultsOpioid-use DisorderNCT04219540NYU Langone Health675
已完成
2 期
Buprenorphine Pharmacology Related to Addiction Treatment - 18Opioid-Related DisordersNCT00000236National Institute on Drug Abuse (NIDA)
